相关实验视频

Updated: May 16, 2025

Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease

Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease

Published on: November 14, 2017

围产期窒息症和阿尔茨海默病:有没有相关性?

Bruna Petrucelli Arruda¹, Pamela Pinheiro Martins¹, Alexandre Hiroaki Kihara²

¹Neurohistology Laboratory, Center for Computation, Mathematics and Cognition, Federal University of ABC, Sao Bernardo do Campo, São Paulo, Brazil.

Frontiers in pediatrics

|April 2, 2025

概括

围产期窒息症是一种出生并发症,可以导致长期的大脑损伤并增加阿尔茨海默病的风险. 这种情况使大脑通过炎症和表观遗传变化进行神经退行.

科学领域:

神经科学是一个神经科学.
发展生物学发展生物学
病理学病理学病理学

背景情况:

围产期发育对于大脑结构和认知功能至关重要.
围产期窒息包括气体交换受损和缺氧,导致神经元损伤.
阿尔茨海默病 (AD) 是一种进展性神经退行性疾病,其特征是粉样质斑块和认知能力下降.

研究的目的:

审查将围产期窒息与长期神经退行性易感性联系在一起的机制,特别是对于阿尔茨海默病.
探索氧化应激,神经炎症和表观遗传修饰的作用.
识别生物标志物,了解早期对阿尔茨海默病的影响.

主要方法:

关于围产期窒息和神经退行症研究的文献综述.
对研究AD病理学并行的动物模型的分析.
对氧化应激,炎症和表观遗传变化的检查.

主要成果:

围产期窒息可以导致持续的神经元损伤并增加AD风险.
氧化应激,神经炎症和表观遗传变化是关键的调解者.
动物模型显示了改变的粉样蛋白前体蛋白,化和微质激活,反映了AD病理.

结论:

围产期窒息可能会在表观遗传上引发微质并改变基因表达,使个体易患慢性神经退行症.
早期的侮辱,如窒息,是晚年神经退行性疾病的重要危险因素.
需要使用先进的奥米克和有机体模型进行进一步的研究,以确认这些联系并制定预防策略.

关键词:

发展发展发展发展发展.在海马体内,海马体缺氧-缺血性脑病变 (hypoxic-ischemic encephalopathy) 是一种缺氧-缺血性脑病变的疾病.新生儿的无氧.神经退行性疾病神经退行性疾病

更多相关视频

Correlative Light and Electron Microscopy to Study Microglial Interactions with β-Amyloid Plaques

Correlative Light and Electron Microscopy to Study Microglial Interactions with β-Amyloid Plaques

Published on: June 1, 2016

Analysis of Learning and Memory Ability in an Alzheimer's Disease Mouse Model using the Morris Water Maze

Analysis of Learning and Memory Ability in an Alzheimer's Disease Mouse Model using the Morris Water Maze

Published on: October 29, 2019

相关概念视频

Alzheimer's Disease: Overview

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...

Alzheimer's Disease: Treatment

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...